Literature DB >> 1803998

Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates.

K J Shaw1, R S Hare, F J Sabatelli, M Rizzo, C A Cramer, L Naples, S Kocsi, H Munayyer, P Mann, G H Miller.   

Abstract

DNA hybridization data and aminoglycoside resistance profiles (AGRPs) were determined for 4,088 clinical isolates from three studies (United States, Belgium, and Argentina). The correlation between susceptibility profiles and hybridization results was determined with nine DNA probes. For each of the seven aminoglycoside resistance profiles which we were able to test, the data suggested at least two distinct genes could encode enzymes which lead to identical resistance profiles. Furthermore, the DNA hybridization data showed that individual strains carried up to six unique aminoglycoside resistance genes. DNA hybridization revealed interesting differences in the frequencies of these genes by organism and by country.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1803998      PMCID: PMC245368          DOI: 10.1128/AAC.35.11.2253

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Cloning and sequencing of a gene encoding an aminoglycoside 6'-N-acetyltransferase from an R factor of Citrobacter diversus.

Authors:  F C Tenover; D Filpula; K L Phillips; J J Plorde
Journal:  J Bacteriol       Date:  1988-01       Impact factor: 3.490

2.  More than one DNA sequence encodes the 2''-O-adenylyltransferase phenotype.

Authors:  S C Lee; P P Cleary; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

3.  Nucleotide sequence analysis of a gene encoding a streptomycin/spectinomycin adenylyltransferase.

Authors:  S Hollingshead; D Vapnek
Journal:  Plasmid       Date:  1985-01       Impact factor: 3.466

4.  Development of two DNA probes for differentiating the structural genes of subclasses I and II of the aminoglycoside-modifying enzyme 3'-aminoglycoside phosphotransferase.

Authors:  S A Young; F C Tenover; T D Gootz; K P Gordon; J J Plorde
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

5.  Intercontinental spread of a new antibiotic resistance gene on an epidemic plasmid.

Authors:  T F O'Brien; M P Pla; K H Mayer; H Kishi; E Gilleece; M Syvanen; J D Hopkins
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  AAC(1): a new aminoglycoside-acetylating enzyme modifying the Cl aminogroup of apramycin.

Authors:  A M Lovering; L O White; D S Reeves
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790

8.  Isolation, characterization, and cloning of a plasmid-borne gene encoding a phosphotransferase that confers high-level amikacin resistance in enteric bacilli.

Authors:  R Gaynes; E Groisman; E Nelson; M Casadaban; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

9.  Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase.

Authors:  T Lambert; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

10.  Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci.

Authors:  H Ounissi; E Derlot; C Carlier; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

View more
  28 in total

1.  Characterization of the chromosomal aac(6')-Ic gene from Serratia marcescens.

Authors:  K J Shaw; P N Rather; F J Sabatelli; P Mann; H Munayyer; R Mierzwa; G L Petrikkos; R S Hare; G H Miller; P Bennett; P Downey
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

Review 2.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 3.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Cloning and characterization of an aminoglycoside 6'-N-acetyltransferase gene from Citrobacter freundii which confers an altered resistance profile.

Authors:  H Y Wu; G H Miller; M G Blanco; R S Hare; K J Shaw
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 5.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Distribution and content of class 1 integrons in different Vibrio cholerae O-serotype strains isolated in Thailand.

Authors:  A Dalsgaard; A Forslund; O Serichantalergs; D Sandvang
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

7.  Aminoglycoside resistance genes aph(2")-Ib and aac(6')-Im detected together in strains of both Escherichia coli and Enterococcus faecium.

Authors:  J W Chow; V Kak; I You; S J Kao; J Petrin; D B Clewell; S A Lerner; G H Miller; K J Shaw
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

8.  Nucleotide sequence analysis and DNA hybridization studies of the ant(4')-IIa gene from Pseudomonas aeruginosa.

Authors:  K J Shaw; H Munayyer; P N Rather; R S Hare; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Detection of aac(6')-I genes in amikacin-resistant Acinetobacter spp. by PCR.

Authors:  M C Ploy; H Giamarellou; P Bourlioux; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 10.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.